Net debt/EBITDA spoločnosti Apellis Pharmaceuticals Inc
Aká je hodnota metriky Net debt/EBITDA spoločnosti Apellis Pharmaceuticals Inc?
Hodnota metriky Net debt/EBITDA spoločnosti Apellis Pharmaceuticals Inc je 5.26
Aká je definícia metriky Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Apellis Pharmaceuticals Inc
Čomu sa venuje spoločnosť Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
Firmy s metrikou net debt/ebitda podobnou spoločnosti Apellis Pharmaceuticals Inc
- Hodnota metriky Net debt/EBITDA spoločnosti Keller Plc je 5.24
- Hodnota metriky Net debt/EBITDA spoločnosti Noxopharm je 5.24
- Hodnota metriky Net debt/EBITDA spoločnosti Enel Americas SA je 5.25
- Hodnota metriky Net debt/EBITDA spoločnosti Alaska Air je 5.25
- Hodnota metriky Net debt/EBITDA spoločnosti Alturas Minerals je 5.25
- Hodnota metriky Net debt/EBITDA spoločnosti Live Nation Entertainment Inc je 5.26
- Hodnota metriky Net debt/EBITDA spoločnosti Apellis Pharmaceuticals Inc je 5.26
- Hodnota metriky Net debt/EBITDA spoločnosti Sunrise Realty Trust je 5.26
- Hodnota metriky Net debt/EBITDA spoločnosti Polished.com Inc je 5.27
- Hodnota metriky Net debt/EBITDA spoločnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA spoločnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA spoločnosti Valneva SE je 5.27
- Hodnota metriky Net debt/EBITDA spoločnosti Solocal S.A je 5.27